ClinicalTrials.gg
Not yet recruitingNCT06404996Updated May 22, 2024

Smart-phone Application Versus Conventional Paper for the Documentation of Voiding Dysfunction in Children

An interventional study of Smart-phone Voiding Diary and Paper voiding diary in Voiding Dysfunction and Children, sponsored by King Abdullah International Medical Research Center. Not yet recruiting. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2024-05-22.

Sponsored by King Abdullah International Medical Research Center · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 3 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
6 Years to 18 Years
Sex
All
01

Study summary

The objective of the research is to compare the written voiding diary method to the smart-phone diary, DryDawn®, which the investigators selected among several applications using specific criteria appropriate to our population. The investigators aim is to describe the method that proves to be most efficient by assessing which diary provides the best quality and amount of information, and draws the highest level of satisfaction from participants.

Patient satisfaction will be assessed using a questionnaire that was designed for use in this study.

Read the detailed description

The idea of using smart-phone applications for the purpose of medical management is not new, however, results from studies have been variable and few have characterized their use in the management of disease in children. The propose of study is to conduct a a research that involves the use of a smart-phone voiding diary application in children.

The intention of this research is to identify which method of documentation, either a smart-phone voiding diary application or the conventional written diary, is most effective in gathering information from urology patients in the pediatric population.

The investigators will conduct a prospective randomized study to investigate which type of diary is better regarding data collection and patient's satisfaction. Consenting individuals will be informed of the study details and their safety will be assured. Patients/parents will be informed of their right to withdraw from the study at any moment.

The two groups refer to the two methods of documentation (diaries) to which will be randomly assigned .The diaries are the smart-phone diary application, DryDawn ® (The Arabic version), or the conventional pen-and-paper method.

A website (www.randomizer.org) will be used to generate a randomized numbered lists that determine participant allocation to one of two study groups.

Data collection will include patient demographics, the type of diary used, as well as the information that participants provide in either of the voiding the diaries and the satisfaction questionnaire. The investigators will analyze the data and report on the percentage of participants who complied with their diary completion, information provided by patients and caregivers in the diary, and the number of participants in the study. Moreover, a questionnaire (Voiding diary Satisfaction Questionnaire) will be given to each family evaluating the patient/caregiver satisfaction.

If the diary has to be repeated, automatically will switch to the other type of diary. A re-evaluation of the diary satisfaction.

02

Conditions studied

  • Voiding Dysfunction
  • Children

Keywords

  • voiding dysfunction
  • bladder
  • children
  • voiding diary
  • smart-phone
03

In context

Lead sponsor

King Abdullah International Medical Research Center is the lead sponsor of 46 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • New patients who have a voiding dysfunction that necessitates the use of a voiding diary
  • Children ages six (6) to eighteen (18) years
  • Participants must own a smart-phone

Exclusion criteria

Exclusion Criteria:

  • Children less than six (6) years of age
  • Participants who do not own a smart-phone
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Smart-phone diary

    smart-phone voiding diary application

    Device: Smart-phone Voiding Diary

  • Active comparator
    Paper diary

    Conventional paper based voiding diary

    Diagnostic Test: Paper voiding diary

Interventions

  • DeviceSmart-phone Voiding Diary

    Smart-phone Voiding Diary

    Also known as: DryDawn

  • Diagnostic testPaper voiding diary

    Conventional Paper voiding diary

06

What researchers measure

Primary outcomes

  1. The percentage of diary completion

    The percentage/number of patients of each group who will complete the diary and send it on-time.

    Time frame: 1 year

Secondary outcomes

  1. Patient's satisfaction assessment by the Voiding diary Satisfaction Questionnaire

    Patient satisfaction will be assessed using a Voiding diary Satisfaction Questionnaire that can assess the ease of use of the diary chosen, as well as the compliance of diary completion and submission. The questionnaire consists of 6 subjective questions. Each question has 2-5 different answers with no objective scale.

    Time frame: 1 year

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Because of data ownership policy of our institution, I may not able to share full data unless approved by the ethical committee

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Aug 2024; primary completion for Aug 2025, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 22, 2024
First posted
May 8, 2024
StartEst.
Aug 1, 2024
Primary completionEst.
Aug 1, 2025
CompletionEst.
Feb 28, 2026
Last update
May 22, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06404996
Lead sponsor
King Abdullah International Medical Research Center
Responsible party
Sponsor
First posted
May 8, 2024
Start date
Aug 1, 2024 (estimated)
Primary completion
Aug 1, 2025 (estimated)
Completion
Feb 28, 2026 (estimated)
Last update
May 22, 2024

Study contacts

Amr Hodhod, MD, PhD, Msc
Contact
hodhodam@mngha.med.sa
+966118011111 ext. 53316
Amr Hodhod, MD, PhD, Msc
principal investigator · King Abdullah International Medical Research Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion